Eleanor Stein

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
eleanorsteinmd.ca

Eleanor (Ellie) Stein, MD, FRCP(C), is a psychiatrist in private practice in Calgary, Alberta, Canada and a Clinical Assistant Professor in the Department of Psychiatry at the University of Calgary.[1] She is the founder of the ETeam, "a unique service in Canada offering specialized multidisciplinary assessment for clients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Fibromyalgia, Multiple Chemical Sensitivity and Toxic Chemical and Mold Exposure."[2]

Awards[edit | edit source]

  • 2007, 13th Annual Florence Nightingale award from the Edmonton ME Society for continued support in the area of education, awareness and research on Myalgic Encephalomyelitis[3]
  • 2007, John MacLennan Award of the Canadian Society for Environmental Medicine for Excellence in the field of Environmental Medicine[3]

Advocacy[edit | edit source]

Notable studies[edit | edit source]

  • 2013, Concerns with fibromyalgia guidelines: Let's not blame patients for lack of knowledge about Fibromyalgia[11]
  • 2013, Identifying and Treating Common Psychiatric Conditions Comorbid with Myalgic Encephalomyelitis and/or Fibromyalgia[12](Full text)
  • 2015, Comment: First Do No Harm: Graded Exercise Therapy and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Comment[13]
  • 2021, Systematic Review of Mind-Body Interventions to Treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[15](Abstract)
  • 2021, Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[16](Full text)

Guidelines and non-peer reviewed articles[edit | edit source]

Talks, presentations and interviews[edit | edit source]

  • 2018, Could Neuroplasticity have a role in ME/CFS? Presented at the Montreal 2018 Canadian Collaborative Team Conference on ME/CFS May 4, 2018.

Videos[edit | edit source]

Invited lecture at the patient day of the International Association of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Conference, Ottawa, Canada September 2011.

Books[edit | edit source]

Clinic location[edit | edit source]

4523-16 A Street SW
Calgary
Alberta
Canada

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. "Eleanor Stein MD Psychiatry and Psychotherapy". Eleanor Stein MD. Retrieved November 14, 2019.
  2. "ETeam". Eleanor Stein MD. Retrieved November 14, 2019.
  3. 3.03.1 "Eleanor Stein B.Sc MD FRCP(C)". Eleanor Stein MD. Retrieved November 14, 2019.
  4. "An open letter to Dr. Richard Horton and The Lancet". Virology blog. Retrieved August 18, 2018.
  5. "Trial By Error: An Open Letter to The Lancet, Two Years On". Virology blog. Retrieved August 18, 2018.
  6. "An open letter to Psychological Medicine about "recovery" and the PACE trial". Virology blog. Retrieved August 18, 2018.
  7. Stein, E. (2001). "Chronic Fatigue Syndrome: Overcoming the Attitudinal Impasse". Journal of Chronic Fatigue Syndrome. 8 (3–4): 53–61. doi:10.1300/J092v08n03_06.
  8. Stein, Eleanor (April 2006). "Classification of somatoform disorders". The American Journal of Psychiatry. 163 (4): 747, author reply 747–748. doi:10.1176/appi.ajp.163.4.747. ISSN 0002-953X. PMID 16585458.
  9. Steffen, Imke; Tyrrell, D. Lorne; Stein, Eleanor; Montalvo, Leilani; Lee, Tzong-Hae; Zhou, Yanchen; Lu, Kai; Switzer, William M.; Tang, Shaohua; Jia, Hongwei; Hockman, Darren; Santer, Deanna M.; Logan, Michael; Landi, Amir; Law, John; Houghton, Michael; Simmons, Graham (November 17, 2011). "No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome". PLoS ONE. 6 (11): e27870. doi:10.1371/journal.pone.0027870. ISSN 1932-6203. PMC 3219700. PMID 22114717.
  10. Olson, Karin; Zimka, Oksana; Stein, Eleanor (October 1, 2015). "The Nature of Fatigue in Chronic Fatigue Syndrome". Qualitative Health Research. 25 (10): 1410–1422. doi:10.1177/1049732315573954. ISSN 1049-7323.
  11. Stein, Eleanor (September 17, 2013). "Concerns with fibromyalgia guidelines". CMAJ. 185 (13): 1160–1160. doi:10.1503/cmaj.113-2132. ISSN 0820-3946. PMC 3778491. PMID 24043754.
  12. Stein, Eleanor (January 18, 2013). "Identifying and Treating Common Psychiatric Conditions Comorbid with Myalgic Encephalomyelitis and/or Fibromyalgia". Psychiatric Times. pp. 15–21.
  13. Chu, L.; Bateman, Lucinda; Davenport, Todd; Stein, E.; Stevens, Staci (July 11, 2015). "First Do No Harm: Graded Exercise Therapy and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Comment". Ann Intern Med. 162 (12).
  14. Olson, Karin; Zimka, Oksana; Stein, Eleanor (October 1, 2015). "The Nature of Fatigue in Chronic Fatigue Syndrome". Qualitative Health Research. 25 (10): 1410–1422. doi:10.1177/1049732315573954. ISSN 1049-7323.
  15. Khanpour Ardestani, Samaneh; Karkhaneh, Mohammad; Stein, Eleanor; Punja, Salima; Junqueira, Daniela R.; Kuzmyn, Tatiana; Pearson, Michelle; Smith, Laurie; Olson, Karin (June 24, 2021). "Systematic Review of Mind-Body Interventions to Treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Medicina (Kaunas, Lithuania). 57 (7): 652. doi:10.3390/medicina57070652. ISSN 1648-9144. PMC 8305555. PMID 34202826.
  16. Chu, Lily; Elliott, Meghan; Stein, Eleanor; Jason, Leonard A. (May 25, 2021). "Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Healthcare. 9 (6): 629. doi:10.3390/healthcare9060629. ISSN 2227-9032. PMC 8227525. PMID 34070367.
  17. Stein, Eleanor; Campbell, Jackie (December 2008/January 2009). "Beyond Tired: Helping patients cope with chronic fatigue syndrome" (PDF). Pharmacy Practice: 14–21. Check date values in: |date= (help)
  18. "ME/CFS Canadian Collaborative Team Conference program" (PDF). Retrieved March 6, 2019.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

somatic symptom disorder A psychiatric term to describe an alleged condition whereby a person's thoughts somehow cause physical symptoms. The actual existence of such a condition is highly controversial, due to a lack of scientific evidence. It is related to other psychiatric terms, such as "psychosomatic", "neurasthenia", and "hysteria". Older terms include "somatization", "somatoform disorder", and "conversion disorder". Such terms refer to a scientifically-unsupported theory that claims that a wide range of physical symptoms can be created by the human mind, a theory which has been criticized as "mind over matter" parapsychology, a pseudoscience.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

graded exercise therapy (GET) - A gradual increase in exercise or activity, according to a pre-defined plan. Focuses on overcoming the patient's alleged unhelpful illness beliefs that exertion can exacerbate symptoms, rather than on reversing physical deconditioning. Considered controversial, and possibly harmful, in the treatment or management of ME. One of the treatment arms of the controversial PACE trial.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.